View Older Stories
-
Celgene (CELG) PT Lowered to $77 at Citi
-
S&P 500 Q2 2018 Buybacks Increase 58.7% Year-Over-Year to Record $190.6 Billion
-
Celgene Corporation to Webcast at Upcoming Investor Conferences
-
Pre-Open Movers 06/29: (GEMP) (DERM) (NKE) Higher; (PFIE) (STZ) (SNX) Lower (more...)
-
Celgene (CELG) PT Lowered to $100 at Citi
-
Pre-Open Movers 04/24: (EVLV) (SANM) (WFT) Higher; (EPZM) (WAT) (MMM) Lower (more...)
-
Pre-Open Movers 04/03: (MGI) (TSLA) (X) Higher; (LFIN) (SWCH) (RIGL) Lower (more...)
-
After-Hours Stock Movers 04/02: (X) Higher; (SWCH) (VIAB) (LFIN) Lower (more...)
-
S&P 500 Q4 2017 Buybacks Rose 6.0% to $137.0 Billion; Full-Year 2017 Fell 3.2% to $519.4 Billion
-
Prothena Corp. (PRTA) Announces Pact with Celgene (CELG) for Novel Therapies for Patients with Neurodegenerative Diseases
-
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
-
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
-
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
-
Celgene Prices $4.5 Billion of Senior Unsecured Notes
-
Celgene Announces Offering of Senior Unsecured Notes
-
Juno Therapeutics (JUNO) Surges on Takeover Report as Wall Street Debates Potential Deal Valuation
-
Juno Therapeutics (JUNO) Worth $110/Share in Takeover - Citi
-
Pre-Open Movers 12/22: (RXDX) (LPJC) (SGH) Higher; (AGRX) (DPW) (LTEA) Lower (more...)
-
UPDATE: Citi Downgrades Celgene (CELG) to Neutral
-
Teva seeks CEO with pharma background to lead recovery efforts
-
Teva Pharma (TEVA) CEO Resigns, Citi Says Covenant Impact Not A Concern
-
Complete Donald Trump Stock Impact Guide
-
Agios Pharma (AGIO) Announces Submission of AG-221 NDA to FDA by Celgene (CELG)
-
Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September
-
Notable Analyst Rating Changes 7/15: (CBL) (SHO) (SEE) Upgraded; (NVDA) (QCOM) (UNM) Downgraded
-
Pre-Open Stock Movers 05/18: (SAAS) (MZOR) (ANDE) Higher; (TGT) (VIPS) (ACXM) Lower (more...)
-
Citi Starts Celgene (CELG) at Buy
-
Celgene Prices $8 Billion of Senior Unsecured Notes
-
Celgene Announces Offering of Senior Unsecured Notes
-
Notable Mergers and Acquisitions 7/15: (CELG)/(RCPT) (MOH) (ETP)/(SUN) (MIDD)
-
Celgene (CELG) to Acquire Receptos (RCPT) for $232/Share
-
Celgene (CELG) to Acquire Receptos (RCPT) in $7.2B Deal
-
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
-
Streetinsider.com's Hot Lunchtime Reads 05/27: (CTRL) (GTAT) (CELG) (RVBD)
-
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
-
Notable Analyst Rating Changes 04/25: (CELG) (SYNA) (WFC) Upgraded; (KLAC) (LLTC) (CYTK) Downgraded
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
Celgene (CELG) PT Bumped to $206 at Citi
-
Notable Analyst Rating Changes 12/10: (CELG) (GERN) (ARIA) Upgraded; (DGX) (HME) (CHL) Downgraded
-
StreetInsider.com Pre-Open Movers 6/12: (CTB) (CYTK) (HMA) Higher; (CLSN) (FSLR) (IEP) Lower (more...)
-
StreetInsider.com Pre-Open Movers 11/12: (TIE) (JEF) (GILD) Higher; (CLVS) (STSI) (GRMN) Lower (more...)
-
Citi Adds Celgene (CELG) to Top Picks Live List, Lifts Target
-
Top 10 News Items 6/18-6/22: Fed Slams the Door on QE3 But Extends Operation Twist; Greek Elections Take Help Ease Pressure; Moody's Downgrades Banks Across the Board
-
Notable Analyst Rating Changes 04/04: (SBUX) (JOY) (CIEN) Upgraded; (ALLT) (MCD) (IBM) Downgraded
-
Pre-Open Movers 10/27: (MF) (AKAM) (BAC) Higher; (TQNT) (MDR) (SFLY) Lower (more...)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
After-Hours Movers 12/06: SPPI, PBY, PLAB Higher; ABMD, GERN, FSYS, BPZ, CELG, SPB, C Lower
-
Citigroup Raises Price Target on Celgene (CELG) to $73
-
Citi Adds Celgene (CELG) to 'Top Pick Live' List; Time to Buy When No One Else Is
-
Citi Adds Celgene (CELG) and Human Genome Sciences (HGSI) to 'Top Picks Live' List

